Medical Oncology

General Hospital Medicine

Questions discussed in this category

How do you approach ADT in patients with high-risk prostate cancer who have risk factors for VTE, such as Factor V Leiden?

1 Answer available

How do you manage anticoagulation/antiplatelet therapies with strong indications for uninterrupted therapy in setting of urgent procedures?

For example, anticoagulation for recent, significant PE or dual antiplatelet therapy for recent MI, but requiring urgent procedures such as biopsy of ...

4 Answers available

For patients with newly diagnosed VTE on IV heparin planned for transition to DOAC, would you start at the loading or maintenance DOAC dose?

If they have been on IV heparin for 3 days, for example, would you subtract those days from the recommended loading dose time?

5 Answers available

Papers discussed in this category

Blood advances, 2018-11-27

American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.

Blood Adv,

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.

Lancet Oncol, 2015 Feb 19

High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.

European urology, 2022 Apr 22

High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.

Arteriosclerosis, thrombosis, and vascular biology, 2020 Sep 03

Lifestyle Moderates Genetic Risk of Venous Thromboembolism: The ARIC Study.

The Lancet. Oncology, 2010 Apr 13

Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden.

Frontiers in cardiovascular medicine, 2022 Mar 16

Association of Gonadotropin-Releasing Hormone Therapies With Venous Thromboembolic Events in Patients With Prostate Cancer: A National Cohort Study.

Cancer, 2015 Jul 06

Prostate cancer, comorbidity, and the risk of venous thromboembolism: A cohort study of 44,035 Danish prostate cancer patients, 1995-2011.

Medical Oncology

General Hospital Medicine

Questions discussed in this category

Papers discussed in this category

Related Topics in Medical Oncology